New findings highlight a potential trade-off between the benefits of GLP-1 therapy and GI risks.
Medscape Medical News
Source link : https://www.medscape.com/s/viewarticle/gerd-risk-higher-glp-1s-vs-sglt2s-2025a1000qmz?src=rss
Author :
Publish date : 2025-10-06 17:25:00
Copyright for syndicated content belongs to the linked Source.